ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Stemona Sessilifolia Extract

Also known as: Radix Stemonae, Stemona sessilifolia extract, Stemona sessilifolia

Overview

Stemona sessilifolia extract is derived from the roots of the plant Stemona sessilifolia, a traditional Chinese medicinal herb. It is primarily known for its rich content of stemona alkaloids, including stemosessifoine, isooxymaistemonine, isomaistemonine, tuberostemonine, and stemoninine. Traditionally, this extract has been utilized in Chinese medicine for the treatment of various respiratory ailments, particularly cough and chronic obstructive pulmonary disease (COPD). While its phytochemical composition is well-characterized, the clinical pharmacology and efficacy data in humans are currently limited. Research on Stemona sessilifolia extract is in its early to moderate stages, with most evidence stemming from in vitro studies, animal models, and limited preclinical investigations. There is a notable absence of high-quality randomized controlled trials (RCTs) or meta-analyses specifically evaluating its effects in human populations, indicating that its clinical utility and safety profile are not yet fully established.

Benefits

Preclinical studies suggest that Stemona sessilifolia extract may offer anti-inflammatory benefits, particularly in models of chronic obstructive pulmonary disease (COPD). In rat models, a Radix Stemonae decoction was observed to reduce lung inflammation and improve lung tissue pathology, alongside a decrease in inflammatory mediators such as TNF-α, IL-8, and LTB4. This indicates a potential role in mitigating inflammatory responses associated with respiratory conditions. Furthermore, some of the isolated alkaloids, such as isooxymaistemonine, have shown in vitro effects on lipid metabolism receptors, potentially influencing HDL receptor gene expression. While traditional uses of Stemona sessilifolia focus on cough suppression and general respiratory symptom relief, it is crucial to note that these traditional claims lack substantiation from robust clinical evidence. Currently, there are no quantified effect sizes or clinical outcomes from randomized controlled trials available to definitively support these benefits in humans.

How it works

The therapeutic effects of Stemona sessilifolia extract are primarily attributed to its active compounds, the stemona alkaloids. These alkaloids are believed to exert their anti-inflammatory effects by inhibiting the release of various inflammatory mediators within the body. For instance, in preclinical models, they have been shown to reduce levels of TNF-α, IL-8, and LTB4, which are key players in inflammatory processes, particularly in the lungs. Additionally, certain alkaloids, such as isooxymaistemonine, have demonstrated an ability to influence gene expression related to lipid metabolism, specifically affecting receptors like CD36 and CLA-1. Absorption studies in rats indicate that key alkaloids like stemoninine and tuberostemonine are bioavailable following oral administration, suggesting they can be absorbed into the bloodstream. However, the detailed molecular targets and specific biological pathways through which these alkaloids exert their effects remain insufficiently characterized and require further investigation.

Side effects

Comprehensive safety data and adverse event profiles for Stemona sessilifolia extract from human clinical trials are currently unavailable. While traditional use suggests a general level of tolerability, formal toxicological studies and detailed drug interaction data are notably lacking. This means that the full spectrum of potential side effects, their severity, and frequency in humans are not well-documented. There are no established contraindications or specific side effect frequencies reported in high-quality clinical studies. Due to the absence of rigorous human safety trials, the potential for adverse reactions, allergic responses, or interactions with prescription medications cannot be adequately assessed. Individuals considering the use of Stemona sessilifolia extract should be aware of this significant knowledge gap regarding its safety profile and potential risks. Caution is advised, especially for pregnant or breastfeeding individuals, those with pre-existing medical conditions, or those taking other medications, as specific warnings or contraindications have not been formally identified.

Dosage

Currently, there are no established or standardized dosing guidelines for Stemona sessilifolia extract derived from human clinical trials. The available research primarily consists of animal studies, which have utilized concentrated decoctions of Radix Stemonae. However, these animal dosages cannot be directly extrapolated to human equivalent doses, and the optimal dosing regimen for various purposes in humans remains undefined. Factors such as the specific formulation (e.g., raw herb, extract, isolated alkaloids), the concentration of active compounds, and their bioavailability are not standardized or well-studied. Consequently, there is no clear information regarding recommended dosage ranges, timing considerations, or different dosages for specific health conditions. Furthermore, safe upper limits and potential toxicity thresholds for human consumption have not been determined. Without robust clinical data, any dosage recommendations would be speculative and potentially unsafe. Therefore, individuals should exercise extreme caution and consult with a qualified healthcare professional before considering the use of Stemona sessilifolia extract, given the lack of evidence-based dosing information.

FAQs

Is Stemona sessilifolia extract clinically proven for respiratory diseases?

No, there are no high-quality randomized controlled trials or meta-analyses in humans to confirm the efficacy of Stemona sessilifolia extract for respiratory diseases. Evidence is primarily preclinical.

Is Stemona sessilifolia extract safe to use?

The safety profile of Stemona sessilifolia extract in humans is unclear due to a significant lack of comprehensive clinical safety data. Formal toxicological studies and adverse event reporting are insufficient.

How does Stemona sessilifolia extract work?

It is believed to work primarily through its stemona alkaloids, which may exert anti-inflammatory effects by inhibiting inflammatory mediator release. Some alkaloids also show potential for modulating lipid metabolism.

When can I expect to see effects from Stemona sessilifolia extract?

Based on preclinical data, potential benefits are suggested for chronic respiratory conditions, but the timing of effects in humans is unknown due to the absence of clinical trials.

Research Sources

  • https://pubmed.ncbi.nlm.nih.gov/18421751/ – This study focuses on the phytochemical analysis of Stemona sessilifolia, identifying new stemona alkaloids. It also reports that one of these alkaloids, isooxymaistemonine, influenced HDL receptor gene expression in an in vitro setting, suggesting a potential role in lipid metabolism.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC5105246/ – This animal study investigated the effects of Radix Stemonae decoction in a rat model of COPD. Findings indicated that the decoction reduced lung inflammation and improved lung tissue pathology, along with decreasing inflammatory mediators like TNF-α, IL-8, and LTB4, suggesting anti-inflammatory properties.
  • https://pubmed.ncbi.nlm.nih.gov/32726680/ – This review summarizes the traditional uses and phytochemical composition of Stemona sessilifolia. It highlights the significant gap in pharmacological and clinical studies, emphasizing the insufficient evidence for its efficacy and safety in human populations despite its traditional applications.